Codelivery of VEGF siRNA and Gemcitabine Monophosphate in a Single Nanoparticle Formulation for Effective Treatment of NSCLC
Author:
Publisher
Elsevier BV
Subject
Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine
Reference28 articles.
1. Overcoming drug resistance of MCF-7/ADR cells by altering intracellular distribution of doxorubicin via MVP knockdown with a novel siRNA polyamidoamine-hyaluronic acid complex;Han;J Control Release,2012
2. VEGF and angiopoietin signaling in tumor angiogenesis and metastasis;Saharinen;Trends Mol Med,2011
3. Vascular-specific growth factors and blood vessel formation;Yancopoulos;Nature,2000
4. Selective VEGFR inhibitors for anticancer therapeutics in clinical use and clinical trials;Zhang;Curr Pharm Des,2012
5. EGFR- and VEGF®-targeted small molecules show synergistic activity in colorectal cancer models refractory to combinations of monoclonal antibodies;Poindessous;Clin Cancer Res,2011
Cited by 111 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Lipid Nanoparticular Codelivery System for Enhanced Antitumor Effects by Ferroptosis–Apoptosis Synergistic with Programmed Cell Death-Ligand 1 Downregulation;ACS Nano;2024-06-13
2. Nucleic acids based integrated macromolecular complexes for SiRNA delivery: Recent advancements;Nucleosides, Nucleotides & Nucleic Acids;2024-05
3. Cell-Derived Allograft Models as a Solution to the Obstacles of Preclinical Studies under Limited Resources: A Systematic Review on Experimental Lung Cancer Animal Models;Current Reviews in Clinical and Experimental Pharmacology;2024-04-24
4. Nanoscale metal-organic frameworks for the delivery of nucleic acids to cancer cells;International Journal of Pharmaceutics: X;2023-12
5. The emerging nanomedicine-based technology for non-small cell lung cancer immunotherapy: how far are we from an effective treatment;Frontiers in Oncology;2023-04-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3